Publication productivity of authors of psoriasis clinical practice guidelines with and without ties to industry - 09/11/19
Funding sources: None. |
|
Conflicts of interest: Dr Feldman is a speaker for Janssen and Taro; consultant and speaker for Galderma, Stiefel/GlaxoSmithKline, Abbott Labs, and Leo Pharma Inc; and consultant for Amgen, Baxter, Caremark, Gerson Lehrman Group, Guidepoint Global, Hanall Pharmaceutical Co Ltd, Kikaku, Lilly, Merck & Co Inc, Merz Pharmaceuticals, Mylan, Novartis Pharmaceuticals, Pfizer Inc, Qurient, Suncare Research, and Xenoport. He has received grants from Galderma, Janssen, Abbott Labs, Amgen, Celgene, Stiefel/GlaxoSmithKline, and Anacor and is on an advisory board for Pfizer Inc. Dr Feldman is the founder and holds stock in Causa Research and holds stock and is a majority owner of Medical Quality Enhancement Corporation. He also receives Royalties from UpToDate and Xlibris. Ms Kolli and Dr Huang have no conflicts of interest to disclose. |
Vol 81 - N° 6
P. 1432-1433 - décembre 2019 Retour au numéroBienvenue sur EM-consulte, la référence des professionnels de santé.
L’accès au texte intégral de cet article nécessite un abonnement.
Déjà abonné à cette revue ?